Treatment-related mortality in children with acute myeloid leukaemia in Central America: Incidence, timing and predictors

European Journal of Cancer

Volumn 48, Issue 9, 2012, Pages 1363-1369

  Gupta, Sumit ^a   Bonilla, Miguel ^b   Valverde, Patricia ^c   Fu, Ligia ^d   Howard, Scott C ^e   Ribeiro, Raul C ^e   Sung, Lillian ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Hospital Nacional de Ninos Benjamin Bloom   (El Salvador)

^c Unidad Nacional de Oncologia Pediatrica   (Guatemala)

^d Hospital Escuela   (Honduras)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Acute myeloid leukaemia; Central America; Child; Developing countries; Treatment related death

Indexed keywords

AMPHOTERICIN B; CIPROFLOXACIN; COTRIMOXAZOLE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUCONAZOLE; MITOXANTRONE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLEEDING; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CENTRAL AMERICA; CLINICAL EVALUATION; CONFIDENCE INTERVAL; DRUG MEGADOSE; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE COUNT; TREATMENT FAILURE;

CENTRAL AMERICA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEVELOPED COUNTRIES; EL SALVADOR; FEMALE; GUATEMALA; HONDURAS; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84861331774     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.10.009     Document Type: Article

References (27)

1. I. Tsukimoto, A. Tawa, and K. Horibe Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 Trial from the Japanese Childhood AML Cooperative Study Group J Clin Oncol 27 24 2009 4007 4013
2. J.E. Rubnitz, H. Inaba, and G. Dahl Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial Lancet Oncol 11 2010 543 552
3. T. Eden, C.H. Pui, M. Schrappe, G. Tognoni, and G. Masera All children have a right to full access to treatment for cancer Lancet 364 2004 1121 1122
4. S.C. Howard, and J.A. Wilimas Delays in diagnosis and treatment of childhood cancer: where in the world are they important? Pediatr Blood Cancer 44 4 2005 303 304
5. U. Creutzig, M. Zimmermann, and D. Reinhardt Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98 J Clin Oncol 22 21 2004 4384 4393
6. J.E. Rubnitz, S. Lensing, and Y. Zhou Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience Cancer 101 7 2004 1677 1684
7. L.C. Riley, I.M. Hann, K. Wheatley, and R.F. Stevens Treatment-related deaths during induction and first remission of acute myeloid leukemia in children treated on the Tenth medical Research Council Acute Myeloid Leukaemia Trial (MRC AML10) Br J Haematol 106 2 1999 436 444
8. L. Molgaard-Hansen, M. Mottonen, and H. Glosli Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 Br J Haematol 151 2010 447 459
9. S. Gupta, M. Bonilla, and S.L. Fuentes Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador Br J Cancer 100 7 2009 1026 1031
10. U. Creutzig, J. Ritter, and M. Zimmermann Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93 Leukemia 15 3 2001 348 354
11. S.O. Lie, J. Abrahamsson, and N. Clausen Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down syndrome. results of NOPHO-AML trials Br J Haematol 122 2 2003 217 225
12. R.S. Arora, T. Eden, and B. Pizer The problem of treatment abandonment in children from developing countries with cancer Pediatr Blood Cancer 49 7 2007 941 946
13. M. Bonilla, N. Rossell, and C. Salaverria Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador Int J Cancer 125 9 2009 2144 2146
14. L. Ayoub, L. Fu, and A. Pena Implementation of a data management program in a pediatric cancer unit in a low income country Pediatr Blood Cancer 49 1 2007 23 27
15. The World Bank. World Development Indicators. 2005. < http://data.worldbank.org/data-catalog/world-development-indicators >.
16. C.L. Ogden, R.J. Kuczmarski, and K.M. Flegal Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version Pediatrics 109 1 2002 45 60
17. A. Sala, E. Rossi, and F. Antillon Nutritional status at diagnosis in children and adolescents with cancer in the AHOPCA (Asociacion de Hemato-Oncologia Pedatrica de Centro America) Countries. Preliminary results from Guatemala Pediatr Blood Cancer 50 2 Suppl. 2008 499 501
18. A.R. Frisancho New norms of upper limb fat and muscle areas for assessment of nutritional status Am J Clin Nutr 34 1981 2540 2545
19. L.L. Chan, M.E. Abdel-Latif, W.A. Ariffin, H. Ariffin, and H.P. Lin Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country Br J Haematol 126 2004 799 805
20. A.M. Slats, R.M. Egeler, and A. van der Does-van den Berg Causes of death - other than progressive leukemia - in childhood acute lymphoblastic leukemia (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience Leukemia 19 4 2005 537 544
21. U. Creutzig, M. Zimmermann, and T. Lehrnbecher Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML BFM 98 J Clin Oncol 24 27 2006 4499 4506
22. B.J. Lange, F.O. Smith, and J. Feusner Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group Blood 111 2008 1044 1053
23. L. Sung, B.J. Lange, R.B. Gerbing, T.A. Alonzo, and J. Feusner Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia Blood 110 10 2007 3532 3539
24. Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database of Systematic Reviews 2005;(4):Art. No: CD004386.
25. A. Gafter-Gvili, M. Paul, A. Fraser, and L. Leibovici Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis J Antimicrob Chemother 59 2007 5 22
26. B. Kurt, P. Flynn, and J.L. Shenep Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia Cancer 113 2008 376 382
27. T. Lehrnbecher, M.-C. Ethier, and T. Zaoutis International variations in infection supportive care practices for paediatric patients with acute myeloid leukemia Br J Haematol 147 2009 125 128